Phase I Study of Ixabepilone Plus Lapatinib With or Without Capecitabine in the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer

Clinical trial NCT00634088 · TERMINATED

Trial details

NCT number: NCT00634088
Sponsor: R-Pharm
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced or Metastatic Breast Cancer

Start date: 2008-06-01
Primary completion: 2010-06-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.